Related Experiment Videos

Passive hemagglutination and complement fixation reactions in the early diagnosis of Mycoplasma pneumoniae infections

Virologie
|October 1, 1976
PubMed

Insights

The passive hemagglutination (PHA) test is a reliable method for diagnosing Mycoplasma pneumoniae infections early. This diagnostic approach aids in guiding timely treatment with macrolides and tetracyclines.

Area of Science:

  • Medical Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Mycoplasma pneumoniae is a common cause of respiratory infections.
  • Early and accurate diagnosis is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the efficacy of complement fixation (CF) and passive hemagglutination (PHA) tests for diagnosing Mycoplasma pneumoniae infections.
  • To determine the optimal diagnostic method for early etiological diagnosis.

Main Methods:

  • Conducted complement fixation (CF) and passive hemagglutination (PHA) tests on 263 patients with infectious and non-infectious diseases.
  • Utilized a M. pneumoniae antigen coupled to red blood cells for the PHA test.
  • Analyzed patient sera from the first and second week post-onset of symptoms.

Main Results:

  • Complement fixation (CF) tests were found inappropriate for early diagnosis due to undifferentiated high titers and significant anticomplementary activity (38%).
  • A passive hemagglutination (PHA) titer of 1/128 or higher (preferably 1/512) strongly suggests M. pneumoniae infection, particularly in cases of nonbacterial or mixed pneumonia.
  • PHA test demonstrated specificity, sensitivity, reproducibility, and ease of performance.

Conclusions:

  • Passive hemagglutination (PHA) is a recommended, sensitive, and specific method for early diagnosis of Mycoplasma pneumoniae infections.
  • Early diagnosis via PHA facilitates timely etiological therapy with macrolides and tetracyclines.
  • CF tests are not recommended for early Mycoplasma pneumoniae diagnosis.

Related Concept Videos